VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $2.3M invested in VistaGen Therapeutics in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$14K
2
+$11K
3
+$1K

Top Sellers

1
-$278K
2
-$3.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.02M
2
$516K
3
$258K
4
$184K
5
$84K
6
$69K
7
$56K
8
$48K
9
$38K
10
$20K
11
$11K
12
$2K
13
$1K